The Company operates in one segment, ophthalmology. The Company develops, manufactures and markets medical devices. Our revenues arise from the sale of consoles, delivery devices, consumables, service, and support activities.

	Three Months Ended				Six Months Ended
(in thousands)	June 29, 2019		June 30, 2018		June 29, 2019		June 30, 2018
G6	$	3,351	$	3,014	$	6,457	$	5,855
Retina		5,248		5,577		10,847		10,488
Other(1)		1,827		1,713		3,717		3,470
Total revenues	$	10,426	$	10,304	$	21,021	$	19,813
(1) Incudes service contract revenues of $296 and $293 and $604 and $597 recognized during the three and six months ended June 29, 2019 and June 30, 2018, respectively. Other also includes revenues from paid service, royalty, freight and legacy G probes.

Revenue information shown by geographic region, based on the sales destination, is as follows:

	Three Months Ended				Six Months Ended
(in thousands)	June 29, 2019		June 30, 2018		June 29, 2019		June 30, 2018
United States	$	5,327	$	5,114	$	10,529	$	9,974
Europe		2,587		2,226		5,064		4,660
Rest of Americas		754		656		1,372		1,308
Asia/Pacific Rim		1,758		2,308		4,056		3,871
Total revenues	$	10,426	$	10,304	$	21,021	$	19,813

Other than the United States, no individual country accounted for more than 10% of the Company’s revenues during the three and six months ended June 29, 2019 and June 30, 2018. The United States accounted for 51.1% and 49.6% of revenues for the three months ended June 29, 2019 and June 30, 2018, respectively. International sales accounted for 48.9% and 50.4% of revenues for the three months ended June 29, 2019 and June 30, 2018, respectively. For the six months ended June 29, 2019 and June 30, 2018, the United States accounted for 50.1% and 50.3% of revenues, respectively. For the six months ended June 29, 2019 and June 30, 2018, international sales accounted for 49.9% and 49.7% of revenues, respectively.